GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
7SQ7 | Q99J21 | Cryo-EM structure of mouse PI(3,5)P2-bound TRPML1 channel at 2.41 Angstrom resolution | |
7SQ8 | Q99J21 | Cryo-EM structure of mouse apo TRPML1 channel at 2.598 Angstrom resolution | |
7SQ9 | Q99J21 | Cryo-EM structure of mouse temsirolimus/PI(3,5)P2-bound TRPML1 channel at 2.11 Angstrom resolution | |
6Q2J | Q99988 | Cryo-EM structure of extracellular dimeric complex of RET/GFRAL/GDF15 | Growth/differentiation factor 15, GDNF family receptor alpha-like, Proto-oncogene tyrosine-protein kinase receptor Ret (E.C.2.7.10.1) |
5YQ5 | Q99983 | Crystal structure of human osteomodulin | |
5V56 | Q99835 | 2.9A XFEL structure of the multi-domain human smoothened receptor (with E194M mutation) in complex with TC114 | |
4N4W | Q99835 | Structure of the human smoothened receptor in complex with SANT-1. | |
5L7D | Q99835 | Structure of human Smoothened in complex with cholesterol | |
5L7I | Q99835 | Structure of human Smoothened in complex with Vismodegib | |
7ZI0 | Q99835 | Structure of human Smoothened in complex with cholesterol and SAG | |
6QHJ | Q99784 | High-resolution crystal structure of calcium- and sodium-bound mouse Olfactomedin-1 beta-propeller domain | |
7W02 | Q99758 | Cryo-EM structure of ATP-bound ABCA3 | |
7W01 | Q99758 | Cryo-EM structure of nucleotide-free ABCA3 | |
6Q2O | Q99748 | Cryo-EM structure of RET/GFRa2/NRTN extracellular complex. The 3D refinement was applied with C2 symmetry. | Neurturin, GDNF family receptor alpha-2, Proto-oncogene tyrosine-protein kinase receptor Ret (E.C.2.7.10.1) |
6Q2R | Q99748 | Cryo-EM structure of RET/GFRa2/NRTN extracellular complex in the tetrameric form | Neurturin, GDNF family receptor alpha-2, Proto-oncogene tyrosine-protein kinase receptor Ret (E.C.2.7.10.1) |
3WYR | Q99706 | Crystal structure of Killer cell immunoglobulin-like receptor 2DL4 | |
8XRP | Q99665 | The Cryo-EM structure of IL-12, receptor subunit beta-1 and receptor subunit beta-2 complex | |
8YI7 | Q99665 | The Cryo-EM structure of IL-12, receptor subunit beta-1 and receptor subunit beta-2 complex, local refinement | |
3A1J | Q99638 | Crystal structure of the human Rad9-Hus1-Rad1 complex | Cell cycle checkpoint control protein RAD9A (E.C.3.1.11.2), Checkpoint protein HUS1, Cell cycle checkpoint protein RAD1 (E.C.3.1.11.2) |
4AW9 | Q99538 | Crystal structure of active legumain in complex with YVAD-CMK | LEGUMAIN (E.C.3.4.22.34), ACE-TYR-VAL-ALA-ASP-CHLOROMETHYLKETONE |
4AWA | Q99538 | Crystal structure of active legumain in complex with YVAD-CMK at pH 5.0 | |
4AWB | Q99538 | Crystal structure of active legumain in complex with AAN-CMK | |
4FGU | Q99538 | Crystal structure of prolegumain | Legumain (E.C.3.4.22.34) |
4N6N | Q99538 | Crystal structure of oxidized legumain in complex with cystatin E/M | |
4N6O | Q99538 | Crystal structure of reduced legumain in complex with cystatin E/M | |
5LU8 | Q99538 | CRYSTAL STRUCTURE OF YVAD-CMK BOUND HUMAN LEGUMAIN (AEP) IN COMPLEX WITH COMPOUND 11B | |
5LU9 | Q99538 | Crystal structure of YVAD-cmk bound human legumain (AEP) in complex with compound 11 | |
5LUA | Q99538 | Crystal structure of human legumain (AEP) in complex with compound 11b | |
5LUB | Q99538 | Crystal structure of human legumain (AEP) in complex with compound 11 | |
7O50 | Q99538 | Crystal structure of human legumain in complex with Gly-Ser-Asn peptide | |
8AE4 | Q99538 | Crystal structure of human legumain in complex with Clitocypin 2 | |
8AE5 | Q99538 | Crystal structure of human legumain in complex with macrocypin 1a | |
7FQH | Q99538 | Crystal Structure of human Legumain in complex with (2S)-N-[(3S)-5-amino-5-oxopent-1-yn-3-yl]-1-[1-[4-(cyclopropylmethoxy)phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide | |
7FQI | Q99538 | Crystal Structure of human Legumain in complex with (2S)-N-[(1S)-3-amino-1-cyano-3-oxopropyl]-1-[1-[4-[(2,4-difluorophenyl)methoxy]phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide | |
7FQJ | Q99538 | Crystal Structure of human Legumain in complex with (2S)-N-[(1S)-3-amino-1-cyano-3-oxopropyl]-1-[1-[4-[(2,4-difluorophenyl)methoxy]phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide | |
7FQK | Q99538 | Crystal Structure of human Legumain in complex with (2S)-N-[(3S)-5-amino-1-(1,3-oxazol-2-yl)-5-oxopent-1-yn-3-yl]-1-[1-[4-(trifluoromethoxy)phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide | |
7FQL | Q99538 | Crystal Structure of human Legumain in complex with (2S)-N-[(1S)-3-amino-1-cyano-3-oxopropyl]-1-[1-[4-[(2,4-difluorophenyl)methoxy]phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide | |
6X3L | Q99523 | Sortilin-Progranulin Interaction With Compound 2 | |
6X48 | Q99523 | Sortilin-Progranulin Interaction With Compound 17 | |
6X4H | Q99523 | Sortilin-Progranulin Interaction With Compound 24 | |
6EHO | Q99523 | Dimer of the Sortilin Vps10p domain at low pH | |
3F6K | Q99523 | Crystal structure of the Vps10p domain of human sortilin/NTS3 in complex with neurotensin | |
4MSL | Q99523 | Crystal structure of the Vps10p domain of human sortilin/NTS3 in complex with AF40431 | Sortilin |
4N7E | Q99523 | Crystal structure of the Vps10p domain of human sortilin/NTS3 in complex with AF38469 | |
4PO7 | Q99523 | Structure of the Sortilin:neurotensin complex at excess neurotensin concentration | Sortilin, Neurotensin |
5MRH | Q99523 | Crystal structure of the Vps10p domain of human sortilin/NTS3 in complex with Triazolone 1 | |
5MRI | Q99523 | Crystal structure of the Vps10p domain of human sortilin/NTS3 in complex with Triazolone 18 | |
8T8R | Q99523 | Sortilin-PGRN peptide complex | |
8T8S | Q99523 | Sortilin-PGRN peptide complex | |
8GJE | Q994M9 | HIV-1 Env subtype C CZA97.12 SOSIP.664 in complex with 3BNC117 Fab |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024